Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03475316 · ClinicalTrials.gov registry record · NA

Movement Intervention for Memory Enhancement

A NA study of Alzheimer Disease and Dementia, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT03475316 is a NA study of Alzheimer Disease and Dementia that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 25 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03475316, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Dancing is a complex sensorimotor rhythmic activity that integrates cognitive, physical, and social components and is applicable to seniors with various fitness levels. Despite its popularity, there is a paucity of studies that have systematically examined the role of dancing in preventing or delaying cognitive decline in older adults at high risk for Alzheimer's disease and related dementias. This preliminary randomized clinical trial will help provide the evidence base to develop a definitive full-scale trial to support or refute prescription of social dancing to prevent further cognitive decline in older adults at high risk of Alzheimer's disease and related dementia.

Interventions

  • BEHAVIORAL Treadmill Walking
  • BEHAVIORAL Social Dancing

Study Locations (1)

New York

  • Albert Einstein College of Medicine - The Bronx

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-03-28
Est. Completion 2020-06-30
Phase NA

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT03475316

The ClinicalTrials.gov registry entry for NCT03475316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Treadmill Walking is the first listed.

NCT03475316 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03475316 about?

NCT03475316 is a clinical study titled "Movement Intervention for Memory Enhancement". Dancing is a complex sensorimotor rhythmic activity that integrates cognitive, physical, and social components and is applicable to seniors with various fitness levels. Despite its popularity, there is a paucity of studies that have systematically examined the role of dancing in preventing or delayi...

What is the current status of trial NCT03475316?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-03-28. Estimated completion is 2020-06-30.

What conditions does trial NCT03475316 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Cognitive Impairment, Cognitive Decline, Dementia Alzheimer Type.

What interventions are being tested in trial NCT03475316?

The interventions under investigation include: Treadmill Walking (BEHAVIORAL), Social Dancing (BEHAVIORAL).

Who is sponsoring clinical trial NCT03475316?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03475316 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.